Capricor Therapeutics (CAPR)
(Delayed Data from NSDQ)
$7.74 USD
+0.07 (0.91%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $7.77 +0.03 (0.39%) 6:44 PM ET
4-Sell of 5 4
F Value D Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Capricor Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Products industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CAPR 7.74 +0.07(0.91%)
Will CAPR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CAPR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CAPR
FDA Rejects CAPR's Cell Therapy BLA for Genetic Disorder, Stock Tanks
Capricor (CAPR) Moves 20.4% Higher: Will This Strength Last?
CAPR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Capricor Therapeutics (CAPR) Reports Q4 Loss, Tops Revenue Estimates
QuidelOrtho (QDEL) Q4 Earnings and Revenues Top Estimates
Strength Seen in Exagen (XGN): Can Its 29.4% Jump Turn into More Strength?
Other News for CAPR
Capricor Therapeutics to Present Second Quarter 2025 Financial Results and Recent Corporate ...
Biotech stocks rise following Prasad exit from FDA
12 Health Care Stocks Moving In Wednesday's Intraday Session
Capricor Therapeutics (CAPR) Sees Increased Bullish Options Activity
Capricor Therapeutics call volume above normal and directionally bullish